Cardiac rehabilitation and secondary prevention after acute myocardial infarction: a modern view on the problem

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Cardiovascular diseases remain a heavy socioeconomic burden in the modern world, claiming up to four million lives annually, including one million of the Russian population. Most often, cardiovascular mortality is associated with chronic coronary heart disease and its complications. Despite the progress in the treatment of acute coronary syndrome in the acute disease phase, the problem of recurrent coronary events and associated adequate rehabilitation remains unresolved. Modern Russian and European recommendations for cardiovascular rehabilitation present the main directions of secondary prevention of myocardial infarction, which summarize the global and Russian evidence-based medicine data on the problem and are based on the principles of phasing, continuity, succession, and multidisciplinary approach to the patient management. This review focuses on the problems and shortcomings of secondary prevention and cardiac rehabilitation at the patient, doctor, and healthcare system levels. In addition, contemporary approaches to their elimination are described. The necessity and importance of individual training and informing patients and the formation of their sustainable commitment to a healthy lifestyle and therapeutic and preventive measures prescribed by modern guidelines on this issue are emphasized.

作者简介

Elena Sayutina

I.M. Sechenov First Moscow State Medical University

编辑信件的主要联系方式.
Email: sayutina_e_v@staff.sechenov.ru
ORCID iD: 0000-0001-9611-5096

MD, Cand. Sci. (Med.), assistant lecturer

俄罗斯联邦, 2/4, Bolshaya Pirogovskaya str., Moscow, 119991

Mikhail Osadchuk

I.M. Sechenov First Moscow State Medical University

Email: osadchuk.mikhail@yandex.ru
ORCID iD: 0000-0003-0485-6802

MD, Dr. Sci. (Med.), рrofessor

俄罗斯联邦, Moscow

Boris Romanov

Pirogov Russian National Research Medical University

Email: bkr@yandex.ru
ORCID iD: 0000-0001-5429-9528

MD, Dr. Sci. (Med.), assistant professor

俄罗斯联邦, Moscow

Elena Tuaeva

I.M. Sechenov First Moscow State Medical University

Email: lenatuaeva@yandex.ru
ORCID iD: 0000-0002-6542-2277

MD, Cand. Sci. (Med.), assistant lecturer

俄罗斯联邦, Moscow

Ludmila Butorova

S.M. Kirov Military Medical Academy (Branch)

Email: ludmilabutorova@mail.ru
ORCID iD: 0000-0003-4689-2844

MD, Cand. Sci. (Med.)

俄罗斯联邦, Moscow

Gyulnara Dibirova

Pirogov Russian National Research Medical University

Email: g.dibirova@mail.ru
ORCID iD: 0000-0002-1500-4974

MD, Cand. Sci. (Med.), assistant professor

俄罗斯联邦, Moscow

Natalya Kireeva

I.M. Sechenov First Moscow State Medical University

Email: kireeva_nat@inbox.ru
ORCID iD: 0000-0002-3467-886X

MD, Cand. Sci. (Med.), assistant professor

俄罗斯联邦, Moscow

Nikolay Korzhenkov

I.M. Sechenov First Moscow State Medical University

Email: korzhenkof@mail.ru
ORCID iD: 0000-0003-1702-7923

MD, Cand. Sci. (Med.), assistant lecturer

俄罗斯联邦, Moscow

参考

  1. Oganov RG, Maslennikova GY. Demographic trends in the Russian Federation: the impact of cardiovascular disease. Cardiovascular Therapy and Prevention. 2012;11(1):5–10. (In Russ). doi: 10.15829/1728-8800-2012-1-5-10
  2. Ryzhikova IB, Pogosova NV, Koltunov IE, Pozdnyakov YuM, Vygodin.A. Long-term effectiveness of secondary prevention in patients with acute coronary syndrome. Cardiovascular Therapy and Prevention. 2009;8(7):59–63. (In Russ).
  3. Pedersen F, Butrymovich V, Kelbæk H, et al. Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI. Journal of the American College of Cardiology. 2014;64(20):2101–2108. doi: 10.1016/j.jacc.2014.08.037
  4. Velders MA, James SK, Libungan B, et al. Prognosis of elderly patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention in 2001 to 2011: A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) registry. American Heart Journal. 2014;167(5):666–673. doi: 10.1016/j.ahj.2014.01.013
  5. Jernberg T, Hasvold P, Henriksson M, et al. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. European Heart Journal. 2015;36(19):1163-1170. doi: 10.1093/eurheartj/ehu505
  6. Kontis V, Mathers CD, Bonita R, et al. Regional contributions of six preventable risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: a modelling study. The Lancet Global Health. 2015;3(12):e746–e757. doi: 10.1016/s2214-109x(15)00179-5
  7. Wilson K, Gibson N, Willan A, Cook D. Effect of Smoking Cessation on Mortality After Myocardial Infarction. Archives of Internal Medicine. 2000;160(7):939–944. doi: 10.1001/archinte.160.7.939
  8. Estruch R, Ros E, Salas-Salvadó J, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. New England Journal of Medicine. 2013;368(14):1279–1290. doi: 10.1056/NEJMoa1200303
  9. Kryuchkova O.N., Itskova E.A., Lutai Y.A., et al. Modern trends in rehabilitation and secondary prevention used after myocardial infarction. Crimean Therapeutic Journal. 2015;(1):25–29. (In Russ).
  10. Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet. 2004;364(9438):937–952. doi: 10.1016/s0140-6736(04)17018-9
  11. Chow CK, Jolly S, Rao-Melacini P, et al. Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes. Circulation. 2010;121(6):750–758. doi: 10.1161/circulationaha.109.891523
  12. Piepoli MF, Corrà U, Dendale P, et al. Challenges in secondary prevention after acute myocardial infarction: A call for action. European Journal of Preventive Cardiology. 2016;23(18):1994–2006. doi: 10.1177/2047487316663873
  13. Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. European Journal of Preventive Cardiology. 2015;23(6):636–648. doi: 10.1177/2047487315569401
  14. Pogosova NV, Oganov RG, Boytsov SA, et al. Monitoring of secondary prevention Coronary artery disease in Russia and Europe: the results of the Russian Part of the International Multicenter Study EUROASPIRE IV. Kardiologiia, 2015;55(12):99–107. (In Russ)
  15. Pogosova NV, Oganov RG, Boitsov SA, et al. Effectiveness of primary prevention of diseases caused by atherosclerosis in patients with high cardiovascular risk in Russia and other European countries (part 2). Kardiologiia, 2017;57(3S):5–16. (In Russ). doi: 10.18087/cardio.2412
  16. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2016;37(29):2315–2381. doi: 10.1093/eurheartj/ehw106
  17. Lalonde F. AACVPR Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs. The Journal of the American Osteopathic Association Book Reviews. 2012;112(11):753–754. doi: 10.7556/jaoa.2012.112.11.753
  18. Nice.org.uk [Internet]. Carson C, Alderson P, Middleton C, et al. National Institute for Health and Care Excellence. Myocardial infarction: cardiac rehabilitation and prevention of further MI. Clinical guideline [accessed 4 March 2015]. Available from: www.nice.org.uk/guidance/cg172.
  19. Aronov DM, Bubnova MG, Lebedeva EV, et al. Rehabilitation and secondary prevention in patients undergoing acute myocardial infarction with ST-segment elevation: Russian clinical guidelines. Moscow; 2014. (In Russ)
  20. Boitsov SA, Pogosova NV, Bubnova MG, et al. National Recommendations “Cardiovascular Prevention 2017” Methodological Recommendations. Russian Journal of Cardeology. 2018;23(6):7–122. (In Russ). doi: 10.15829/1560-4071-2018-6-7-122
  21. Aronov DM, Bubnova, Ivanova GE. Organizational bases of Cardiological rehabilitation in Russia: current stage. CardioSomatics. 2012;(4):46–54. (In Russ).
  22. Piepoli MF, Corrà U, Adamopoulos S, et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery. European Journal of Preventive Cardiology. 2012;21(6):664–681. doi: 10.1177/2047487312449597
  23. Dalal HM, Doherty P, Taylor RS. Cardiac rehabilitation. BMJ. 2015;351:h5000. doi: 10.1136/bmj.h5000
  24. Bjarnason-Wehrens B, McGee H, Zwisler A-D, et al. Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey. European Journal of Cardiovascular Prevention & Rehabilitation. 2010;17(4):410-418. doi: 10.1097/HJR.0b013e328334f42d
  25. Voller H, Reibis R, Schwaab B, et al. Hospital-based rehabilitation units. In: Voller H, Reibis R, Schwaab B, et al. The ESC Textbook of Preventive Cardiology, Part 4. Setting and delivery of preventive cardiology. Oxford: Oxford University Press; 2015. P. 285–293.
  26. Connolly S and Cupples M. Community-based prevention centres. In: Gielen S, De Backer G, Piepoli M, Wood D. The ESC Textbook of Preventive Cardiology, Part 4. Setting and delivery of preventive cardiology. Oxford: Oxford University Press; 2015. P. 312–319.
  27. Wood DA. EUROACTION: A European Society of Cardiology demonstration project in preventive cardiology.: A cluster randomised controlled trial of a multi-disciplinary preventive cardiology programme for coronary patients, asymptomatic high risk individuals and their families. Summary of design, methodology and outcomes. European Heart Journal Supplements. 2004;6(Suppl J):j3–j15. doi: 10.1093/eurheartj/6.suppl_j.j3
  28. Jorstad HT, von Birgelen C, Alings AMW, et al. Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial. Heart. 2013;99(19):1421–1430. doi: 10.1136/heartjnl-2013-303989
  29. Giannuzzi P. Global Secondary Prevention Strategies to Limit Event Recurrence After Myocardial Infarction. Archives of Internal Medicine. 2008;168(20):2194–2204. doi: 10.1001/archinte.168.20.2194
  30. Fidan D, Unal B, Critchley J, Capewell S. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010. Qjm. 2007;100(5):277–289. doi: 10.1093/qjmed/hcm020
  31. Oldridge NB, Pakosh MT, Thomas RJ. Cardiac rehabilitation in low- and middle-income countries: a review on cost and cost-effectiveness. International Health. 2016;8(2):77–82. doi: 10.1093/inthealth/ihv047
  32. Brown TM, Hernandez AF, Bittner V, et al. Predictors of Cardiac Rehabilitation Referral in Coronary Artery Disease Patients. Journal of the American College of Cardiology. 2009;54(6):515–521. doi: 10.1016/j.jacc.2009.02.080
  33. Karmali KN, Davies P, Taylor F, et al. Promoting patient uptake and adherence in cardiac rehabilitation. Cochrane Database of Systematic Reviews. 2014;(6):CD007131. doi: 10.1002/14651858.CD007131.pub3
  34. Clark AM, King-Shier KM, Duncan A, et al. Factors influencing referral to cardiac rehabilitation and secondary prevention programs: a systematic review. European Journal of Preventive Cardiology. 2013;20(4):692–700. doi: 10.1177/2047487312447846
  35. McCorry NK, Corrigan M, Tully MA, et al. Perceptions of exercise among people who have not attended cardiac rehabilitation following myocardial infarction. Journal of Health Psychology. 2009;14(7):924–932. doi: 10.1177/1359105309341144
  36. Jack BW. A Reengineered Hospital Discharge Program to Decrease Rehospitalization. Annals of Internal Medicine. 2009;150(3):178–187. doi: 10.7326/0003-4819-150-3-200902030-00007
  37. Piepoli MF, Corrà U, Abreu A, et al. Challenges in secondary prevention of cardiovascular diseases. International Journal of Cardiology. 2015;180:114–119. doi: 10.1016/j.ijcard.2014.11.107
  38. Cole JA, Smith SM, Hart N, et al. Do practitioners and friends support patients with coronary heart disease in lifestyle change? A qualitative study. BMC Family Practice. 2013;14(1):1–10.
  39. Naderi SH, Bestwick JP, Wald DS. Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 Patients. The American Journal of Medicine. 2012;125(9):882–887.e881. doi: 10.1016/j.amjmed.2011.12.013
  40. Corrao G, Conti V, Merlino L, et al. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Clinical Therapeutics. 2010;32(2):300–310. doi: 10.1016/j.clinthera.2010.02.004
  41. Aubert RE, Yao J, Xia F, et al. Is there a relationship between early statin compliance and a reduction in healthcare utilization? Am J Manag Care. 2010;16:459–466.
  42. Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews. 2014 (11):CD000011. doi: 10.1002/14651858.CD000011.pub4
  43. Ryzhikova IB, Pogosova NV, Koltunov IE et al. Long-term effectiveness of secondary prevention in patients with acute coronary syndrome. Cardiovascular Therapy and Prevention. 2009;8(7):59–63.(In Russ).
  44. Nesterov YI. Heart attack secondary prevention in primary link of public health service (lecture). Current Issues of Heart and Vascular Diseases. 2009;(2):67–71.
  45. Pietle J.D., Heisler M., Krein S. et al. The role of patient-physician trust in moderation medication nonadherence due to coast pressures. Arch Intern Med. 2005;165(15):1749–1755.
  46. Garkina SV, Simerzin VV, Reut LI. Comparative effectiveness of different organizational approaches to teaching elderly patients with CHF. Bulletin of the St. Petersburg State Academy named after I.I. Mechnikov. I.I. Mechnikov. Special issue. 2009;(2/1):10–14. (In Russ).
  47. Gillebert TC, Brooks N, Fontes-Carvalho R, et al. ESC Core Curriculum for the General Cardiologist (2013). European Heart Journal. 2013;34(30):2381–2411. doi: 10.1093/eurheartj/eht234
  48. OECD [Internet]. Length of hospital stay [accessed 4 March 2015]. Available at: https://data.oecd.org/ healthcare/length-of-hospital-stay.htm.
  49. Taheri PA, Butz DA, Greenfield LJ. Length of stay has minimal impact on the cost of hospital admission 11 No competing interests declared. Journal of the American College of Surgeons. 2000;191(2):123–130. doi: 10.1016/s1072-7515(00)00352-5
  50. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal. 2018;39(2):119–177. doi: 10.1093/eurheartj/ehx393
  51. Mercado MG, Smith DK, McConnon ML. Myocardial infarction: management of the subacute period. Am Fam Physician. 2013;88(9):581–588.
  52. Jack BW, Chetty VK, Anthony D, et al. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med. 2009;150(3):178–187. doi: 10.7326/0003-4819-150-3-200902030-00007
  53. Clancy CM. Reengineering Hospital Discharge: A Protocol to Improve Patient Safety, Reduce Costs, and Boost Patient Satisfaction. American Journal of Medical Quality. 2009;24(4):344–346. doi: 10.1177/1062860609338131
  54. Wachter RM. The Hospitalist Movement 5 Years Later. Jama. 2002;287(4):487–494. doi: 10.1001/jama.287.4.487
  55. Coleman EA, Min S-j, Chomiak A, Kramer AM. Posthospital Care Transitions: Patterns, Complications, and Risk Identification. Health Services Research. 2004;39(5):1449–1466. doi: 10.1111/j.1475-6773.2004.00298.x
  56. Nieuwlaat R, Schwalm J-D, Khatib R, Yusuf S. Why are we failing to implement effective therapies in cardiovascular disease? European Heart Journal. 2013;34(17):1262–1269. doi: 10.1093/eurheartj/ehs481
  57. Piepoli MF, Binno S, Corrà U, et al. ExtraHF survey: the first European survey on implementation of exercise training in heart failure patients. European Journal of Heart Failure. 2015;17(6):631–638. doi: 10.1002/ejhf.27
  58. Hobbs FDR, Jukema JW, Da Silva PM, et al. Barriers to cardiovascular disease risk scoring and primary prevention in Europe. QJM. 2010;103(10):727–739. doi: 10.1093/qjmed/hcq122
  59. Grace SL. Effect of Cardiac Rehabilitation Referral Strategies on Utilization Rates. Archives of Internal Medicine. 2011;171(3): 235–241. doi: 10.1001/archinternmed.2010.501
  60. Pogosova NV, Sokolova OY, Yufereva YM, et al. First Results of Analysis of the Russian Part of the European Register on Cardiac Rehabilitation EuroCaReD (European Cardiac Rehabilitation Database). Kardiologiia. 2015;2:49–56. (In Russ). doi: 10.18565/cardio.2015.2.49-56
  61. Boytsov SA, Ipatov PV, Kalinina AM, et al. Dispenserization of certain groups of the adult population. Guidelines. Moscow: Federal’noe gosudarstvennoe byudzhetnoe uchrezhdenie “Natsional'nyy meditsinskiy issledovatel’skiy tsentr profilakticheskoy meditsiny” Ministerstva zdravookhraneniya Rossiyskoy Federatsii; 2015. (In Russ).
  62. Kalinina AM, Gomova TA, Kushunina DV, et al. Preventive activity of general practitioners in outpatient polyclinic institutions as an important factor in the effectiveness of dispensary and dispensary supervision (regional experience). Preventive Medicine. 2016;19(4):15–22. (In Russ).
  63. Anderson L, Taylor RS. Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews. Cochrane Database of Systematic Reviews. 2014;2021(12). doi: 10.1002/14651858.CD011273.pub2
  64. Anderson L, Oldridge N, Thompson DR, et al. Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease. Journal of the American College of Cardiology. 2016;67(1):1–12. doi: 10.1016/j.jacc.2015.10.044
  65. Clark RA, Conway A, Poulsen V, et al. Alternative models of cardiac rehabilitation: A systematic review. European Journal of Preventive Cardiology. 2013;22(1):35–74. doi: 10.1177/2047487313501093
  66. McAlister FA, Lawson FME, Teo KK, Armstrong PW. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ. 2001;323(7319):957–962. doi: 10.1136/bmj.323.7319.957
  67. Murchie P. Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care. BMJ. 2003;326(7380):84–84. doi: 10.1136/bmj.326.7380.84
  68. Allen JK, Dennison-Himmelfarb CR, Szanton SL, et al. Community Outreach and Cardiovascular Health (COACH) Trial. Circulation: Cardiovascular Quality and Outcomes. 2011;4(6):595–602. doi: 10.1161/circoutcomes.111.961573
  69. Uchmanowicz I, Lisiak M, Wontor R, et al. Frailty Syndrome in cardiovascular disease: Clinical significance and research tools. European Journal of Cardiovascular Nursing. 2015;14(4):303–309. doi: 10.1177/1474515114568059
  70. Neubeck L, Redfern Ju, Fernandez R, et al. Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review. European Journal of Cardiovascular Prevention & Rehabilitation. 2009;16(3):281–289. doi: 10.1097/HJR.0b013e32832a4e7a
  71. Varnfield M, Karunanithi M, Lee C-K, et al. Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial. Heart. 2014;100(22):1770–1779. doi: 10.1136/heartjnl-2014-305783

版权所有 © Sayutina E.V., Osadchuk M.A., Romanov B.K., Tuaeva E.M., Butorova L.I., Dibirova G.O., Kireeva N.V., Korzhenkov N.P., 2022

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。
 


##common.cookie##